{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:50:27Z","timestamp":1781545827230,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Research Grants Council of Hong Kong","award":["GRF grant: 14106318"],"award-info":[{"award-number":["GRF grant: 14106318"]}]},{"DOI":"10.13039\/501100004853","name":"The Chinese University of Hong Kong","doi-asserted-by":"crossref","award":["Direct Grant: 4054428"],"award-info":[{"award-number":["Direct Grant: 4054428"]}],"id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00204-021-03193-y","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T10:03:05Z","timestamp":1637229785000},"page":"639-651","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Fasting augments pyrrolizidine alkaloid-induced hepatotoxicity"],"prefix":"10.1007","volume":"96","author":[{"given":"Jiang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4586-2603","authenticated-orcid":false,"given":"Ge","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"issue":"1","key":"3193_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2133\/dmpk.dmpk-10-rv-089","volume":"26","author":"TA Baillie","year":"2011","unstructured":"Baillie TA, Rettie AE (2011) Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism. Drug Metab Pharmacokinet 26(1):15\u201329. https:\/\/doi.org\/10.2133\/dmpk.dmpk-10-rv-089","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"3193_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0378-4274(95)03407-2","volume":"81","author":"BL Brown","year":"1995","unstructured":"Brown BL, Allis JW, Simmons JE, House DE (1995) Fasting for less than 24 h induces cytochrome P450 2E1 and 2B1\/2 activities in rats. Toxicol Lett 81(1):39\u201344. https:\/\/doi.org\/10.1016\/0378-4274(95)03407-2","journal-title":"Toxicol Lett"},{"issue":"4","key":"3193_CR3","first-page":"263","volume":"4","author":"P Chauvin","year":"1994","unstructured":"Chauvin P, Dillon JC, Moren A (1994) An outbreak of Heliotrope food poisoning, Tadjikistan, November 1992-March 1993. Sante 4(4):263\u2013268","journal-title":"Sante"},{"issue":"3","key":"3193_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0168-8278(03)00231-9","volume":"39","author":"M Chojkier","year":"2003","unstructured":"Chojkier M (2003) Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids. J Hepatol 39(3):437\u2013446. https:\/\/doi.org\/10.1016\/S0168-8278(03)00231-9","journal-title":"J Hepatol"},{"issue":"3","key":"3193_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/hep.510230326","volume":"23","author":"LD DeLeve","year":"1996","unstructured":"DeLeve LD, Wang XD, Kuhlenkamp JF, Kaplowitz N (1996) Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 23(3):589\u2013599","journal-title":"Hepatology"},{"issue":"6","key":"3193_CR6","doi-asserted-by":"publisher","first-page":"G1045","DOI":"10.1152\/ajpgi.00526.2002","volume":"284","author":"LD DeLeve","year":"2003","unstructured":"DeLeve LD, Ito Y, Bethea NW, McCuskey MK, Wang XD, McCuskey RS (2003) Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome. Am J Physiol-Gastr L 284(6):G1045\u2013G1052. https:\/\/doi.org\/10.1152\/ajpgi.00526.2002","journal-title":"Am J Physiol-Gastr L"},{"issue":"3","key":"3193_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0163-7258(91)90029-L","volume":"52","author":"LD Deleve","year":"1991","unstructured":"Deleve LD, Kaplowitz N (1991) Glutathione metabolism and its role in hepatotoxicity. Pharmacol Therapeut 52(3):287\u2013305. https:\/\/doi.org\/10.1016\/0163-7258(91)90029-L","journal-title":"Pharmacol Therapeut"},{"key":"3193_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.fct.2018.03.005","volume":"115","author":"B Dusemund","year":"2018","unstructured":"Dusemund B, Nowak N, Sommerfeld C, Lindtner O, Schafer B, Lampen A (2018) Risk assessment of pyrrolizidine alkaloids in food of plant and animal origin. Food Chem Toxicol 115:63\u201372. https:\/\/doi.org\/10.1016\/j.fct.2018.03.005","journal-title":"Food Chem Toxicol"},{"key":"3193_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-020-02779-2","author":"J Ebmeyer","year":"2020","unstructured":"Ebmeyer J, Rasinger JD, Hengstler JG et al (2020) Hepatotoxic pyrrolizidine alkaloids induce DNA damage response in rat liver in a 28-day feeding study. Arch Toxicol. https:\/\/doi.org\/10.1007\/s00204-020-02779-2","journal-title":"Arch Toxicol"},{"issue":"1","key":"3193_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1021\/tx500403t","volume":"28","author":"JA Edgar","year":"2015","unstructured":"Edgar JA, Molyneux RJ, Colegate SM (2015) Pyrrolizidine alkaloids: potential role in the etiology of cancers, pulmonary hypertension, congenital anomalies, and liver disease. Chem Res Toxicol 28(1):4\u201320. https:\/\/doi.org\/10.1021\/tx500403t","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"3193_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1021\/acs.chemrestox.6b00297","volume":"30","author":"PP Fu","year":"2017","unstructured":"Fu PP (2017) Pyrrolizidine alkaloids: metabolic activation pathways leading to liver tumor initiation. Chem Res Toxicol 30(1):81\u201393. https:\/\/doi.org\/10.1021\/acs.chemrestox.6b00297","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"3193_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1081\/Dmr-120028426","volume":"36","author":"PP Fu","year":"2004","unstructured":"Fu PP, Xia QS, Lin G, Chou MW (2004) Pyrrolizidine alkaloid\u2014genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev 36(1):1\u201355. https:\/\/doi.org\/10.1081\/Dmr-120028426","journal-title":"Drug Metab Rev"},{"issue":"6","key":"3193_CR13","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00204-021-03060-w","volume":"95","author":"Y He","year":"2021","unstructured":"He Y, Zhu L, Ma J, Lin G (2021) Metabolism-mediated cytotoxicity and genotoxicity of pyrrolizidine alkaloids. Arch Toxicol 95(6):1917\u20131942. https:\/\/doi.org\/10.1007\/s00204-021-03060-w","journal-title":"Arch Toxicol"},{"issue":"1","key":"3193_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00204-019-02582-8","volume":"94","author":"S Hessel-Pras","year":"2020","unstructured":"Hessel-Pras S, Braeuning A, Guenther G et al (2020) The pyrrolizidine alkaloid senecionine induces CYP-dependent destruction of sinusoidal endothelial cells and cholestasis in mice. Arch Toxicol 94(1):219\u2013229. https:\/\/doi.org\/10.1007\/s00204-019-02582-8","journal-title":"Arch Toxicol"},{"issue":"1\u20132","key":"3193_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3109\/03602539409029805","volume":"26","author":"JA Hinson","year":"1994","unstructured":"Hinson JA, Pumford NR, Nelson SD (1994) The role of metabolic activation in drug toxicity. Drug Metab Rev 26(1\u20132):395\u2013412. https:\/\/doi.org\/10.3109\/03602539409029805","journal-title":"Drug Metab Rev"},{"key":"3193_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/313280","volume":"2010","author":"F Kakar","year":"2010","unstructured":"Kakar F, Akbarian Z, Leslie T et al (2010) An outbreak of hepatic veno-occlusive disease in Western afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids. J Toxicol 2010:313280. https:\/\/doi.org\/10.1155\/2010\/313280","journal-title":"J Toxicol"},{"issue":"10","key":"3193_CR17","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s40262-017-0515-7","volume":"56","author":"LA Lammers","year":"2017","unstructured":"Lammers LA, Achterbergh R, van Schaik RHN, Romijn JA, Mathot RAA (2017) Effect of short-term fasting on systemic cytochrome P450-mediated drug metabolism in healthy subjects: a randomized, controlled, crossover study using a cocktail approach. Clin Pharmacokinet 56(10):1231\u20131244. https:\/\/doi.org\/10.1007\/s40262-017-0515-7","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"3193_CR18","first-page":"1475","volume":"28","author":"G Lin","year":"2000","unstructured":"Lin G, Cui YY, Hawes EM (2000) Characterization of rat liver microsomal metabolites of clivorine, an hepatotoxic otonecine-type pyrrolizidine alkaloid. Drug Metab Dispos 28(12):1475\u20131483","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"3193_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jhep.2010.07.031","volume":"54","author":"G Lin","year":"2011","unstructured":"Lin G, Wang JY, Li N et al (2011) Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol 54(4):666\u2013673. https:\/\/doi.org\/10.1016\/j.jhep.2010.07.031","journal-title":"J Hepatol"},{"issue":"6","key":"3193_CR20","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cmet.2016.06.001","volume":"23","author":"VD Longo","year":"2016","unstructured":"Longo VD, Panda S (2016) Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan. Cell Metab 23(6):1048\u20131059. https:\/\/doi.org\/10.1016\/j.cmet.2016.06.001","journal-title":"Cell Metab"},{"key":"3193_CR21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.fct.2019.04.057","volume":"129","author":"Y Lu","year":"2019","unstructured":"Lu Y, Ma J, Lin G (2019) Development of a two-layer transwell co-culture model for the in vitro investigation of pyrrolizidine alkaloid-induced hepatic sinusoidal damage. Food Chem Toxicol 129:391\u2013398. https:\/\/doi.org\/10.1016\/j.fct.2019.04.057","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"3193_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jfda.2015.06.001","volume":"23","author":"L Ma","year":"2015","unstructured":"Ma L, Zhao H, Xia Q, Cai L, Fu PP (2015) Synthesis and phototoxicity of isomeric 7,9-diglutathione pyrrole adducts: formation of reactive oxygen species and induction of lipid peroxidation. J Food Drug Anal 23(3):577\u2013586. https:\/\/doi.org\/10.1016\/j.jfda.2015.06.001","journal-title":"J Food Drug Anal"},{"issue":"3","key":"3193_CR23","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jfda.2018.05.005","volume":"26","author":"J Ma","year":"2018","unstructured":"Ma J, Xia Q, Fu PP, Lin G (2018) Pyrrole-protein adducts\u2014a biomarker of pyrrolizidine alkaloid-induced hepatotoxicity. J Food Drug Anal 26(3):965\u2013972. https:\/\/doi.org\/10.1016\/j.jfda.2018.05.005","journal-title":"J Food Drug Anal"},{"issue":"6","key":"3193_CR24","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1021\/acs.chemrestox.8b00369","volume":"32","author":"J Ma","year":"2019","unstructured":"Ma J, Ruan J, Chen X et al (2019) Pyrrole-hemoglobin adducts, a more feasible potential biomarker of pyrrolizidine alkaloid exposure. Chem Res Toxicol 32(6):1027\u20131039. https:\/\/doi.org\/10.1021\/acs.chemrestox.8b00369","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"3193_CR25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00204-020-02947-4","volume":"95","author":"J Ma","year":"2021","unstructured":"Ma J, Zhang W, He Y et al (2021) Clinical application of pyrrole-hemoglobin adducts as a biomarker of pyrrolizidine alkaloid exposure in humans. Arch Toxicol 95(2):759\u2013765. https:\/\/doi.org\/10.1007\/s00204-020-02947-4","journal-title":"Arch Toxicol"},{"key":"3193_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.toxlet.2016.05.002","volume":"263","author":"KH Merz","year":"2016","unstructured":"Merz KH, Schrenk D (2016) Interim relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicines. Toxicol Lett 263:44\u201357. https:\/\/doi.org\/10.1016\/j.toxlet.2016.05.002","journal-title":"Toxicol Lett"},{"issue":"3","key":"3193_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/bcp.12628","volume":"80","author":"RA Moore","year":"2015","unstructured":"Moore RA, Derry S, Wiffen PJ, Straube S (2015) Effects of food on pharmacokinetics of immediate release oral formulations of aspirin, dipyrone, paracetamol and NSAIDs\u2014a systematic review. Br J Clin Pharmacol 80(3):381\u2013388. https:\/\/doi.org\/10.1111\/bcp.12628","journal-title":"Br J Clin Pharmacol"},{"key":"3193_CR28","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-nutr-071816-064634","volume":"37","author":"RE Patterson","year":"2017","unstructured":"Patterson RE, Sears DD (2017) Metabolic effects of intermittent fasting. Annu Rev Nutr 37:371\u2013393. https:\/\/doi.org\/10.1146\/annurev-nutr-071816-064634","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"3193_CR29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/0016-5085(79)90275-0","volume":"77","author":"D Pessayre","year":"1979","unstructured":"Pessayre D, Dolder A, Artigou JY et al (1979) Effect of fasting on metabolite-mediated hepatotoxicity in the rat. Gastroenterology 77(2):264\u2013271","journal-title":"Gastroenterology"},{"issue":"1","key":"3193_CR30","first-page":"8","volume":"13","author":"J Pizzorno","year":"2014","unstructured":"Pizzorno J (2014) Glutathione! Integr Med (encinitas) 13(1):8\u201312","journal-title":"Integr Med (encinitas)"},{"issue":"4","key":"3193_CR31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0006-2952(87)90346-7","volume":"36","author":"VF Price","year":"1987","unstructured":"Price VF, Miller MG, Jollow DJ (1987) Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat. Biochem Pharmacol 36(4):427\u2013433","journal-title":"Biochem Pharmacol"},{"key":"3193_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.toxlet.2017.10.011","volume":"282","author":"MK Rasmussen","year":"2018","unstructured":"Rasmussen MK, Bertholdt L, Gudiksen A, Pilegaard H, Knudsen JG (2018) Impact of fasting followed by short-term exposure to interleukin-6 on cytochrome P450 mRNA in mice. Toxicol Lett 282:93\u201399. https:\/\/doi.org\/10.1016\/j.toxlet.2017.10.011","journal-title":"Toxicol Lett"},{"issue":"1","key":"3193_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jhep.2013.07.039","volume":"60","author":"O Robinson","year":"2014","unstructured":"Robinson O, Want E, Coen M et al (2014) Hirmi Valley liver disease: a disease associated with exposure to pyrrolizidine alkaloids and DDT. J Hepatol 60(1):96\u2013102. https:\/\/doi.org\/10.1016\/j.jhep.2013.07.039","journal-title":"J Hepatol"},{"issue":"1","key":"3193_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1021\/tx4004159","volume":"27","author":"J Ruan","year":"2014","unstructured":"Ruan J, Liao C, Ye Y, Lin G (2014a) Lack of metabolic activation and predominant formation of an excreted metabolite of nontoxic platynecine-type pyrrolizidine alkaloids. Chem Res Toxicol 27(1):7\u201316. https:\/\/doi.org\/10.1021\/tx4004159","journal-title":"Chem Res Toxicol"},{"issue":"6","key":"3193_CR35","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1021\/tx500071q","volume":"27","author":"J Ruan","year":"2014","unstructured":"Ruan J, Yang M, Fu PP, Ye Y, Lin G (2014b) Metabolic activation of pyrrolizidine alkaloids: insights into the structural and enzymatic basis. Chem Res Toxicol 27(6):1030\u20131039. https:\/\/doi.org\/10.1021\/tx500071q","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"3193_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith PK, Krohn RI, Hermanson GT et al (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150(1):76\u201385. https:\/\/doi.org\/10.1016\/0003-2697(85)90442-7","journal-title":"Anal Biochem"},{"issue":"1","key":"3193_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF03168215","volume":"60","author":"T Szkudelski","year":"2004","unstructured":"Szkudelski T, Okulicz M, Bialik I, Szkudelska K (2004) The influence of fasting on liver sulfhydryl groups, glutathione peroxidase and glutathione-S-transferase activities in the rat. J Physiol Biochem 60(1):1\u20136. https:\/\/doi.org\/10.1007\/BF03168215","journal-title":"J Physiol Biochem"},{"issue":"1","key":"3193_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/oxfordjournals.jbchem.a130387","volume":"75","author":"N Tateishi","year":"1974","unstructured":"Tateishi N, Higashi T, Shinya S, Naruse A, Sakamoto Y (1974) Studies on the regulation of glutathione level in rat liver. J Biochem 75(1):93\u2013103. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a130387","journal-title":"J Biochem"},{"issue":"1","key":"3193_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejps.2004.10.006","volume":"24","author":"M Turpeinen","year":"2005","unstructured":"Turpeinen M, Uusitalo J, Jalonen J, Pelkonen O (2005) Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay. Eur J Pharm Sci 24(1):123\u2013132. https:\/\/doi.org\/10.1016\/j.ejps.2004.10.006","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"3193_CR40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1139\/y82-058","volume":"60","author":"RM Walker","year":"1982","unstructured":"Walker RM, Massey TE, McElligott TF, Racz WJ (1982) Acetaminophen toxicity in fed and fasted mice. Can J Physiol Pharmacol 60(3):399\u2013404","journal-title":"Can J Physiol Pharmacol"},{"issue":"23","key":"3193_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000942","volume":"94","author":"X Wang","year":"2015","unstructured":"Wang X, Qi X, Guo X (2015) Tusanqi-related sinusoidal obstruction syndrome in China: a systematic review of the literatures. Med (baltim) 94(23):e942. https:\/\/doi.org\/10.1097\/MD.0000000000000942","journal-title":"Med (baltim)"},{"issue":"23","key":"3193_CR42","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1001\/jama.1994.03520230055038","volume":"272","author":"DC Whitcomb","year":"1994","unstructured":"Whitcomb DC, Block GD (1994) Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 272(23):1845\u20131850","journal-title":"JAMA"},{"key":"3193_CR43","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0140-6736(01)00020-4","volume":"2","author":"FC Willmot","year":"1920","unstructured":"Willmot FC, Robertson GW (1920) Senecio disease, or cirrhosis of the liver due to senecio poisoning. Lancet 2:848\u2013849","journal-title":"Lancet"},{"issue":"1","key":"3193_CR44","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1006\/taap.1995.1017","volume":"130","author":"CC Yan","year":"1995","unstructured":"Yan CC, Huxtable RJ (1995) Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver. Toxicol Appl Pharm 130(1):132\u2013139. https:\/\/doi.org\/10.1006\/taap.1995.1017","journal-title":"Toxicol Appl Pharm"},{"key":"3193_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cbi.2015.09.011","volume":"243","author":"MB Yang","year":"2016","unstructured":"Yang MB, Ruan JQ, Fu PP, Lin G (2016) Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity. Chem-Biol Interact 243:119\u2013126. https:\/\/doi.org\/10.1016\/j.cbi.2015.09.011","journal-title":"Chem-Biol Interact"},{"issue":"8","key":"3193_CR46","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s00204-019-02499-2","volume":"93","author":"M Yang","year":"2019","unstructured":"Yang M, Ma J, Ruan J, Ye Y, Fu PP, Lin G (2019) Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids. Arch Toxicol 93(8):2197\u20132209. https:\/\/doi.org\/10.1007\/s00204-019-02499-2","journal-title":"Arch Toxicol"},{"issue":"1","key":"3193_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1081\/dmr-200028812","volume":"37","author":"S Zhou","year":"2005","unstructured":"Zhou S, Chan E, Duan W, Huang M, Chen YZ (2005) Drug bioactivation, covalent binding to target proteins and toxicity relevance. Drug Metab Rev 37(1):41\u2013213. https:\/\/doi.org\/10.1081\/dmr-200028812","journal-title":"Drug Metab Rev"},{"issue":"8","key":"3193_CR48","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41401-020-00553-9","volume":"42","author":"L Zhu","year":"2021","unstructured":"Zhu L, Zhang CY, Li DP et al (2021) Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China. Acta Pharmacol Sin 42(8):1212\u20131222. https:\/\/doi.org\/10.1038\/s41401-020-00553-9","journal-title":"Acta Pharmacol Sin"},{"issue":"10","key":"3193_CR49","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1111\/liv.13684","volume":"38","author":"YZ Zhuge","year":"2018","unstructured":"Zhuge YZ, Wang Y, Zhang F et al (2018) Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease. Liver Int 38(10):1867\u20131874. https:\/\/doi.org\/10.1111\/liv.13684","journal-title":"Liver Int"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-03193-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-021-03193-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-03193-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T09:04:07Z","timestamp":1644570247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-021-03193-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["3193"],"URL":"https:\/\/doi.org\/10.1007\/s00204-021-03193-y","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"assertion":[{"value":"18 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}